NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ · Healthcare
NeuroOne Medical Technologies Corporation Shareholder Equity 2020–2025
NeuroOne Medical Technologies Corporation annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- NeuroOne Medical Technologies Corporation shareholder equity as of September 30, 2025: 7.1M, a 760.39% increase year-over-year.
- NeuroOne Medical Technologies Corporation shareholder equity for 2025 were 7.1M, a 760.39% increase from 2024.
- NeuroOne Medical Technologies Corporation shareholder equity for 2024 were 822,013, a 86.85% decrease from 2023.
- NeuroOne Medical Technologies Corporation shareholder equity for 2023 were 6.2M, a 34.93% decrease from 2022.
- NeuroOne Medical Technologies Corporation shareholder equity for 2022 were 9.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| NeuroOne Medical Technologies Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $1 |
| 2023 | $6 |
| 2022 | $10 |
| 2021 | $7 |
| 2020 | $2 |
NeuroOne Medical Technologies Corporation Shareholder Equity — FAQ
NeuroOne Medical Technologies Corporation (NMTC) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NMTC's shareholder equity history?
The chart and table above show NeuroOne Medical Technologies Corporation's shareholder equity by year and by quarter, including the growth rate.